Laser vs shock waves: which zaps shoulder pain best?
NCT ID NCT07615920
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two non-invasive treatments—high-intensity laser therapy and shock wave therapy—for people with chronic shoulder pain from supraspinatus tendinitis. Researchers will measure pain and disability in 48 adults over several weeks to see which approach works better. Neither treatment involves surgery or medication.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- High-Intensity Laser Therapy and Extracorporeal Shock Wave Therapy
- What this could lead to
- If one therapy works better, it could offer a more effective, non-surgical option for easing chronic shoulder pain.
- What could go wrong
- This is a small, early-stage trial with only 48 participants, so results may not apply to everyone. Both treatments are generally safe but may not provide lasting relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 48 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male and female participants aged between 18 and 60 years. * Clinically diagnosed supraspinatus tendinitis confirmed by ultrasound imaging. * Shoulder pain duration greater than 3 months. * Ability to understand and follow study instructions. * Willingness to participate and provide informed consent. Exclusion Criteria: * Full-thickness rotator cuff tear. * Previous shoulder surgery. * Pregnancy. * Neurological disorders affecting the upper limb. * Corticosteroid injection within the previous 3 months. * Shoulder fracture or dislocation. * Systemic inflammatory diseases. * Participation in other physical therapy programs during the study period
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Supraspinatus tendinitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.